You have 1 free searches left this month | for more free features.

Immune suppressive therapy

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immune Checkpoint Inhibitor Monotherapy or Combined With

Not yet recruiting
  • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
Jan 30, 2023

Last Period Not Earlier Than 6 Months Ago Trial in Moscow (oral menopausal hormone therapy, transdermal menopausal hormone

Active, not recruiting
  • Last Period Not Earlier Than 6 Months Ago
  • oral menopausal hormone therapy
  • transdermal menopausal hormone therapy
  • Moscow, Russian Federation
    Federal State Budget Institution Research Center for Obstetrics,
Jan 9, 2023

Actinic Keratosis, Photodynamic Therapy Trial in Fairborn (Celecoxib 200mg, Placebo)

Recruiting
  • Actinic Keratosis
  • Photodynamic Therapy
  • Celecoxib 200mg
  • Placebo
  • Fairborn, Ohio
    Wright State Physicians
Jan 9, 2023

Immune-related Adverse Events Refractory to Standard Therapy and

Recruiting
  • Immune-related Adverse Event
  • Extracorporeal photopheresis
  • Other immunosuppressive or immunomodulatory drugs
  • Munich, Germany
    LMU Klinikum Hauttumorzentrum
Jan 17, 2023

Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

Completed
  • Gastrointestinal Tumor
  • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
  • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
  • Hangzhou, China
    Zhejiang Hospital
Sep 1, 2023

Immune-related Colitis, Colitis Trial in Minneapolis (RMT, Placebo)

Not yet recruiting
  • Immune-related Colitis
  • Colitis
  • Minneapolis, Minnesota
    University of Minnesota
Feb 4, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Adjuvant Immune Checkpoint Inhibitors in Postoperative

Recruiting
  • Hepatocellular Carcinoma
  • Immune Checkpoint Inhibitors Based Adjuvant therapy
  • Nanning, Guangxi, China
    Jian-Hong Zhong
Jan 18, 2023

Pediatric Cancer Trial in Charlotte (Vaccine)

Recruiting
  • Pediatric Cancer
  • Vaccine
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 27, 2023

Immune Markers in Pediatric ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
  • (no location specified)
Oct 17, 2023

Determine Pro-Inflammatory Cytokine Kinetics During Immune

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Melanoma
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jan 30, 2023

    Sepsis, Severe Trial in Germany (ARTICE)

    Recruiting
    • Sepsis, Severe
    • ARTICE
    • Braunschweig, Germany
    • +3 more
    Jul 29, 2022

    Neoadjuvant Therapy in Rectal Cancer

    Recruiting
    • Rectal Cancer
    • Immune checkpoint measure
    • Istanbul, Turkey
      Istanbul Training and Research Hospital
    Jul 9, 2022

    Healthcare Resource Utilization and Costs of Immune Checkpoint

    Completed
    • Melanoma
      • East Hanover, New Jersey
        Novartis
      May 12, 2023

      Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

      Recruiting
      • Secondary Hemophagocytic Lymphohistiocytosis
      • Chronic Active Epstein-Barr Virus Infection
      • No intervention
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      May 2, 2023

      Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Stereotactic body radiotherapy (SBRT)
      • +4 more
      • New York, New York
        Columbia University Irving Medical Center
      Sep 15, 2023

      Immune Reconstitution to CMV After HSCT: Impact of Clinical

      Enrolling by invitation
      • CMV Infection
      • Hematopoietic Stem Cell Transplantation
      • Beijing, Beijing, China
      • +1 more
      Jan 5, 2023

      Lung Cancer Trial in Wuhan (Pirfenidone)

      Recruiting
      • Lung Cancer
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Mar 24, 2023

      Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

      Active, not recruiting
      • Acute Myelogenous Leukemia
      • Myelodysplastic Syndrome
      • Gemtuzumab Ozogamicin
      • Valhalla, New York
        New York Medical College
      Sep 26, 2022

      Melanoma Trial in Durham (Tetanus Diptheria Vaccine, Polio Boost Immunization)

      Recruiting
      • Melanoma
      • Tetanus Diptheria Vaccine
      • Polio Boost Immunization
      • Durham, North Carolina
        Duke University Medical Center
      Sep 8, 2022

      HIV-infected Patients Switching to Long Acting Dual Therapy

      Not yet recruiting
      • HIV-1-infection
        • (no location specified)
        Jun 24, 2022

        Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)

        Recruiting
        • Immune-Mediated Colitis
        • Tofacitinib 10 mg
        • Montreal, Quebec, Canada
          Sir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
        May 11, 2022

        Lentiviral-based Gene-edited Immune Cell Therapy

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma
        • +4 more
        • Pell's lentiviral-based gene-edited immune cell therapy
        • Kaohsiung, Taiwan
        • +2 more
        Oct 25, 2022

        Cancer, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors Trial in Zurich (Fecal Microbiota Transplantation (FMT))

        Recruiting
        • Cancer
        • +2 more
        • Fecal Microbiota Transplantation (FMT)
        • Zurich, Switzerland
          University of Zurich, University Hospital Zurich
        Jun 14, 2022

        Metastatic Melanoma Trial in Stockholm (Precision Radiation (SBRT))

        Recruiting
        • Metastatic Melanoma
        • Precision Radiation (SBRT)
        • Stockholm, Sweden
          Division of Head-Neck, Lung and Skin cancers, Theme Cancer, Karo
        Aug 16, 2022